Le Pogam, S., Yan, J. M., Chhabra, M., Ilnicka, M., Kang, H., Kosaka, A., . . . Nájera, I. (2012). Characterization of Hepatitis C Virus (HCV) Quasispecies Dynamics upon Short-Term Dual Therapy with the HCV NS5B Nucleoside Polymerase Inhibitor Mericitabine and the NS3/4 Protease Inhibitor Danoprevir. American Society for Microbiology.
Citação norma ChicagoLe Pogam, S., et al. Characterization of Hepatitis C Virus (HCV) Quasispecies Dynamics Upon Short-Term Dual Therapy With the HCV NS5B Nucleoside Polymerase Inhibitor Mericitabine and the NS3/4 Protease Inhibitor Danoprevir. American Society for Microbiology, 2012.
Citação norma MLALe Pogam, S., et al. Characterization of Hepatitis C Virus (HCV) Quasispecies Dynamics Upon Short-Term Dual Therapy With the HCV NS5B Nucleoside Polymerase Inhibitor Mericitabine and the NS3/4 Protease Inhibitor Danoprevir. American Society for Microbiology, 2012.